Concordia Healthcare Corp. T.CXR.R

I reiterate...

[sunshine7]

CXR would not have added 100 sales folks to the previous 75 assigned to US Donnatal product if they were concerned about earnings. This is not the behaviour of a company that is concerned about debt payment risk or meeting guidance. IMO they will meet guidance next Wed and CXR SP will surpass VRX.

[DeathPool]

Sunshine7, Most pharma sales reps have commission based compensation packages.  Its like Future Shop increasing their sales force - no sales, no comp and nothing lost.  Sorry, I just don't see adding sales reps as a valid argument that supports an optimistic report.  Just my opinion.

[visionaryfool]

Sunshine7 has a point. Yes, sales reps are commision based and they wouldn't join a company where the prospects of selling a drug are low. This is NOT like Futureshop where your commissions are shitty and your market is limited to whoever comes to you. A good sales rep can walk away with six figures easily and increasing them allows you to talk to more doctors. I'm excited for the call

[DeathPool]

Visionary.   Point taken.  The comparison to Future Shop where I was alluding to when they doubled their sales force months before closing stores was an unfair comparison to make.  But I still maintain my position that an increase in sales force is not a compelling argument that in any way supports that we will meet guidance.  I have been following the cafepharma message board

[JustforFun7]

even if they dont meet guidance...as long as they show an ability to pay downdebt and the new business numers dont look too bad, there is a lot of upside to this.  What he says  will have as much as impact as the numbers.  Lots of info needed.  JFF7

[Windsorman]

I agree totally with your premise. Expect CEO to emphasize that the debt is managable and is being reduced each quarter. I expect the revenue numbers to be inline with guidance and positive outlook. I have been buying the last couple days as Valeant effect has desimated CRX shares. Great long term investment IMHO. GLTA

[Health123]

Is the CEO now doing the CC?   I thought Borkowski was slated to do it.  [ quote=Windsorman]I agree totally with your premise. Expect CEO to emphasize that the debt is managable and is being reduced each quarter. I expect the revenue numbers to be inline with guidance and positive outlook. I have been buying the last couple days as Valeant effect has desimated CRX shares. Great long